Literature DB >> 25586197

Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.

David I Rosenthal1, Abdallah S R Mohamed, Randal S Weber, Adam S Garden, Parag R Sevak, Merril S Kies, William H Morrison, Jan S Lewin, Adel K El-Naggar, Lawrence E Ginsberg, Esengul Kocak-Uzel, K Kian Ang, Clifton David Fuller.   

Abstract

BACKGROUND: The current study was conducted to evaluate long-term disease control, survival, and functional outcomes after surgical and nonsurgical initial treatment for patients with T4 larynx cancer.
METHODS: Demographics, disease stage, and treatment characteristics were reviewed for 221 sequential patients treated for T4 laryngeal squamous cell cancer at a single institution between 1983 and 2011. Survival and disease control outcomes were calculated.
RESULTS: The median follow-up time was 47 months (71 months for patients still alive at the time of analysis). The overall 5-year and 10-year overall survival rates were 52% and 29%, respectively, and the corresponding disease-free survival rates were 57% and 48%, respectively. Overall 5-year and 10-year locoregional control rates were 78% and 67%, respectively, and the corresponding rates for freedom from distant metastasis were 76% and 74%, respectively. On both univariate and multivariate analyses, lymph node-positive disease at the time of presentation was associated with overall mortality (P<.0001). Patients treated with laryngectomy followed by postlaryngectomy radiotherapy (161 patients) achieved better initial locoregional control than patients treated with a laryngeal preservation (LP) approach (60 patients) throughout the follow-up period (log-rank P<.007) yet the median overall survival times were equal for both groups (64 months; 95% confidence interval 47-87 months and 38-87 months, respectively [P =.7]). Patients treated with an LP approach had a tracheostomy rate of 45% and an any-event aspiration rate of 23%. Rates of high-grade dysphagia at the time of last follow-up were worse for patients treated with an LP approach (P<.01).
CONCLUSIONS: Surgery and postoperative radiotherapy can produce substantial long-term cancer control and survival rates for patients with T4 larynx cancer. Caution should be taken when selecting patients for initial nonsurgical treatment because of significant rates of functional impairment despite survival equivalence.
© 2015 American Cancer Society.

Entities:  

Keywords:  T4; laryngeal preservation; laryngectomy; larynx cancer; locally advanced; radiotherapy; survival

Mesh:

Year:  2015        PMID: 25586197      PMCID: PMC4424158          DOI: 10.1002/cncr.29241

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

2.  Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.

Authors:  Henry T Hoffman; Kimberly Porter; Lucy H Karnell; Jay S Cooper; Randall S Weber; Corey J Langer; Kie-Kian Ang; Greer Gay; Andrew Stewart; Robert A Robinson
Journal:  Laryngoscope       Date:  2006-09       Impact factor: 3.325

3.  Treatment volume and tissue tolerance.

Authors:  H R Withers; J M Taylor; B Maciejewski
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-04       Impact factor: 7.038

4.  Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients.

Authors:  B R Pauloski; A W Rademaker; J A Logemann; L A Colangelo
Journal:  Otolaryngol Head Neck Surg       Date:  1998-05       Impact factor: 3.497

5.  Importance of patient examination to clinical quality assurance in head and neck radiation oncology.

Authors:  David I Rosenthal; Joshua A Asper; Jerry L Barker; Adam S Garden; K S Clifford Chao; William H Morrison; Randal S Weber; K Kian Ang
Journal:  Head Neck       Date:  2006-11       Impact factor: 3.147

6.  Salvage laryngectomy for unsuccessful larynx preservation therapy.

Authors:  D H Kraus; D G Pfister; L B Harrison; R H Spiro; E W Strong; M Zelefsky; G J Bosl; J P Shah
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-12       Impact factor: 1.547

7.  The evaluation of treatment of patients with extensive squamous cancer of the vocal cords.

Authors:  R H Jesse
Journal:  Laryngoscope       Date:  1975-09       Impact factor: 3.325

8.  Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.

Authors:  Johnny Kao; Amir Lavaf; Marita S Teng; Delphine Huang; Eric M Genden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

9.  Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible?

Authors:  Lyon L Gleich; John Ryzenman; Jack L Gluckman; Keith M Wilson; William L Barrett; Kevin P Redmond
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-01

10.  Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.

Authors:  B R Knab; J K Salama; A Solanki; K M Stenson; E E Cohen; M E Witt; D J Haraf; E E Vokes
Journal:  Ann Oncol       Date:  2008-05-07       Impact factor: 32.976

View more
  31 in total

1.  Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancer.

Authors:  A Fondevilla Soler; J L López-Guerra; A García Fernández; M A Samaniego Conde; M J Belmonte González; J M Praena-Fernandez; E Rivin Del Campo; M Alcaraz; I Azinovic
Journal:  Clin Transl Oncol       Date:  2018-11-30       Impact factor: 3.405

2.  Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.

Authors:  Gregory T Wolf; Emily Bellile; Avraham Eisbruch; Susan Urba; Carol R Bradford; Lisa Peterson; Mark E Prince; Theodoros N Teknos; Douglas B Chepeha; Norman D Hogikyan; Scott A McLean; Jeffery Moyer; Jeremy M G Taylor; Francis P Worden
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-04-01       Impact factor: 6.223

Review 3.  Organ Preservation Protocols in T4 Laryngeal Cancer: a Review of the Literature.

Authors:  Narayana Subramaniam; Deepak Balasubramanian; Rithvik Reddy; Krishnakumar Thankappan; Subramania Iyer
Journal:  Indian J Surg Oncol       Date:  2018-12-01

4.  Modifications in the treatment of advanced laryngeal cancer throughout the last 30 years.

Authors:  Jacinto García Lorenzo; Victoria Montoro Martínez; Antonio Rigo Quera; Alberto Codina Aroca; Montserrat López Vilas; Miquel Quer Agustí; Xavier León Vintró
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-17       Impact factor: 2.503

5.  Organ preservation surgery for patients with T4a laryngeal cancer.

Authors:  Caiyun Zhang; Minhui Zhu; Donghui Chen; Shicai Chen; Hongliang Zheng
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-02       Impact factor: 2.503

6.  Association of Positive Initial Margins With Survival Among Patients With Squamous Cell Carcinoma Treated With Total Laryngectomy.

Authors:  Patrick Tassone; Corey Savard; Michael C Topf; William Keane; Adam Luginbuhl; Joseph Curry; David Cognetti
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-11-01       Impact factor: 6.223

7.  Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx.

Authors:  Jay C Shiao; Abdallah S R Mohamed; Jay A Messer; Katherine A Hutcheson; Jason M Johnson; Heiko Enderling; Mona Kamal; Benjamin W Warren; Brian Pham; William H Morrison; Mark E Zafereo; Amy C Hessel; Stephen Y Lai; Merril S Kies; Renata Ferrarotto; Adam S Garden; Donald F Schomer; G Brandon Gunn; Jack Phan; Steven J Frank; Beth M Beadle; Randal S Weber; Jan S Lewin; David I Rosenthal; Clifton D Fuller
Journal:  Head Neck       Date:  2017-05-02       Impact factor: 3.147

8.  Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.

Authors:  Collin F Mulcahy; Abdallah S R Mohamed; Aasheesh Kanwar; Katherine A Hutcheson; Alokananda Ghosh; David Vock; Randal S Weber; Stephen Y Lai; Gary Brandon Gunn; Mark Zafereo; William H Morrison; Renata Ferrarotto; Adam S Garden; David I Rosenthal; Clifton D Fuller
Journal:  Head Neck       Date:  2018-05-13       Impact factor: 3.147

9.  Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol.

Authors:  Gorkem Eskiizmir; Gokce Tanyeri Toker; Onur Celik; Kivanc Gunhan; Ayca Tan; Hulya Ellidokuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-10       Impact factor: 2.503

10.  Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.

Authors:  Clifton D Fuller; Abdallah S R Mohamed; Adam S Garden; G Brandon Gunn; Collin F Mulcahy; Mark Zafereo; Jack Phan; Stephen Y Lai; Jan S Lewin; Katherine A Hutcheson; Steven J Frank; Beth M Beadle; William H Morrison; Adel K El-Naggar; Esengul Kocak-Uzel; Lawrence E Ginsberg; Merril S Kies; Randal S Weber; David I Rosenthal
Journal:  Head Neck       Date:  2016-07-28       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.